ORI Capital

As a healthcare fund, we hope to be both financially successful and socially impactful

Our Team

Founder & Senior Partner

Simone Song

Partner

Dicky To

Director

Elaine Yang

Senior Associate

Vincent Chang

Senior Associate

James Huang

Research Analyst

Otto Cheung

Research Analyst

Sarah Mak

Financial Controller

Cathy Choi

In-house Counsel

Edward Tung

HR & Office Manager

Gillian Zhou

Our Portfolio

Exited

Read More

The only company to date that can apply stem cell therapy to cure type 1 diabetes

Read More

World’s first fully humanized antibodies selection platform generating disease-modifying drugs

Listed

NASDAQ:ORTX

Read More

World’s leading gene therapy company targeting multiple diseases with limited or no existing treatment

The first ever high-volume biologic injector

The only company to date that can deliver drugs to pancreatic tumors using its innovative delivery device

First IVD company in tumor testing space making precision medicine the first-line treatment

The leading oncolytic virus company in Phase 3 bladder cancer

Developing CAR-T therapy focusing on brand new target for solid tumor

The world’s first cloud-based platform for AI medical imaging analysis

Cutting edge anti-aging nutraceutical company